# FDA Inspection 1041185 - Carter BloodCare - Tyler - February 02, 2018

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-tyler/66c0c8ed-82d5-4a81-b403-e670932eaa62
Source feed: FDA_Inspections

> FDA Inspection 1041185 for Carter BloodCare - Tyler on February 02, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041185
- Company Name: Carter BloodCare - Tyler
- Inspection Date: 2018-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1264020 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-tyler/cacbeea7-7a64-49aa-9538-42239c080e1a)
- [FDA Inspection 1264020 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-tyler/001baed7-4cec-41c9-a0aa-7bbb2c1f7c3e)
- [FDA Inspection 1173367 - 2022-06-16](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-tyler/16093f97-22da-40c9-b9d3-18ff54a80d40)
- [FDA Inspection 1173367 - 2022-06-16](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-tyler/590dc770-4977-4b46-aeec-7de90e71a9a7)
- [FDA Inspection 974966 - 2016-06-01](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-tyler/ce943196-1cb0-49c1-a00d-65431596f973)

Company: https://www.keypedia.com/companies/carter-bloodcare-tyler/dc81e28f-3ee5-4b46-92ec-04901dd3199b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d